Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DTP Vaccine
Potency of pertussis component in DTP vaccine in Poland evaluated
February 20th, 2005
Researchers present an overview of a 3-decade study in Poland on the potency of the pertussis component in DTP vaccines in a recent issue of the journal Biologicals. "In Poland, similar to many highly immunized Western countries, a recent increase in cases of pertussis has been observed. This study aims to evaluate the level of potency fluctuations of the pertussis component of Polish-produced DTP vaccine due to the changes having occurred in production and potency testing procedures. We compared the potency of the pertussis component of DTP vaccine lots produced and evaluated in similar periods and with similar production and testing procedures. Records of...
Source: Medical Letter on the CDC & FDA (2005-02-20)
|
